Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis

Yu Zhong(Central South University), Li Su(Sichuan University), Shuqi Dai(Yichun University), Hong Huo(China Medical University)
Frontiers in Oncology
August 18, 2022
Cited by 15


Related Papers